Association between baseline body mass index and survival in men with metastatic hormone‐sensitive prostate cancer: ECOG‐ACRIN CHAARTED E3805

Metformin may offer no protective effect in men undergoing external beam radiation therapy for prostate cancer

(2019) Weranja K.B. Ranasinghe et al.   BJU INTERNATIONAL

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial

(2018) Christos E. Kyriakopoulos et al.   JOURNAL OF CLINICAL ONCOLOGY

Metformin Use Is Associated with Improved Survival in Patients with Advanced Prostate Cancer on Androgen Deprivation Therapy

(2018) Kyle A. Richards et al.   JOURNAL OF UROLOGY

The Effect of Metformin Use during Docetaxel Chemotherapy on Prostate Cancer Specific and Overall Survival of Diabetic Patients with Castration Resistant Prostate Cancer

(2017) Michelle J. Mayer et al.   JOURNAL OF UROLOGY

Metformin and Prostate Cancer: a New Role for an Old Drug

(2017) Jessica Whitburn et al.   Current Urology Reports

Minimal important differences for fatigue patient reported outcome measures—a systematic review

(2016) Åsa Nordin et al.   BMC Medical Research Methodology

Postdiagnosis Weight Change and Survival Following a Diagnosis of Early-Stage Breast Cancer

(2016) Elizabeth M. Cespedes Feliciano et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Addition of docetaxel, zoledronic acid, or both to first-line long-term hormone therapy in prostate cancer (STAMPEDE): survival results from an adaptive, multiarm, multistage, platform randomised controlled trial

(2016) Nicholas D James et al.   LANCET

An Open-Label Pilot Study of Metformin as a Concomitant Therapy on Patients with Prostate Cancer Undergoing Androgen Deprivation Treatment

(2016) Wenhui Zhu et al.   UROLOGIA INTERNATIONALIS

Association of Metformin Use with Outcomes in Advanced Endometrial Cancer Treated with Chemotherapy

(2016) Obiageli Ezewuiro et al.   PLoS One

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer

(2015) Christopher J. Sweeney et al.   NEW ENGLAND JOURNAL OF MEDICINE

Metformin in Chemotherapy-naive Castration-resistant Prostate Cancer: A Multicenter Phase 2 Trial (SAKK 08/09)

(2014) Christian Rothermundt et al.   EUROPEAN UROLOGY

Quality of Life, Body Mass Index, and Physical Activity Among Uterine Cancer Patients

(2014) Lilie L. Lin et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Influence of concurrent medications on outcomes of men with prostate cancer included in the TAX 327 study

(2013) Saroj Niraula et al.   CUAJ-Canadian Urological Association Journal

Living alone, obesity and smoking: Important factors for quality of life after radiotherapy and androgen deprivation therapy for prostate cancer

(2012) Karin B. Dieperink et al.   ACTA ONCOLOGICA

Prognostic influence of metformin as first-line chemotherapy for advanced nonsmall cell lung cancer in patients with type 2 diabetes

(2011) Ben-Xu Tan et al.   CANCER

Weight Gain Is Associated with an Increased Risk of Prostate Cancer Recurrence after Prostatectomy in the PSA Era

(2011) C. E. Joshu et al.   Cancer Prevention Research

Body Mass Index, Prostate Cancer-Specific Mortality, and Biochemical Recurrence: a Systematic Review and Meta-analysis

(2011) Y. Cao et al.   Cancer Prevention Research

Presence of the metabolic syndrome is associated with shorter time to castration-resistant prostate cancer

(2010) J. Flanagan et al.   ANNALS OF ONCOLOGY

The association of weight gain during adulthood with prostate cancer incidence and survival: A population-based cohort

(2010) Charlotte Chamberlain et al.   INTERNATIONAL JOURNAL OF CANCER

Body Mass Index, Physical Activity, and Health-Related Quality of Life in Cancer Survivors

(2010) CHRIS M. BLANCHARD et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Associations between lifestyle factors and quality of life among older long-term breast, prostate, and colorectal cancer survivors

(2009) Catherine E. Mosher et al.   CANCER

Incident cancer burden attributable to excess body mass index in 30 European countries

(2009) Andrew G. Renehan et al.   INTERNATIONAL JOURNAL OF CANCER

Metformin and Pathologic Complete Responses to Neoadjuvant Chemotherapy in Diabetic Patients With Breast Cancer

(2009) Sao Jiralerspong et al.   JOURNAL OF CLINICAL ONCOLOGY

Risk of Urinary Incontinence Following Prostatectomy: The Role of Physical Activity and Obesity

(2009) Kathleen Y. Wolin et al.   JOURNAL OF UROLOGY

The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level

(2008) I Ben Sahra et al.   ONCOGENE

Estimating Clinically Meaningful Changes for the Functional Assessment of Cancer Therapy—Prostate: Results from a Clinical Trial of Patients with Metastatic Hormone-Refractory Prostate Cancer

(2008) David Cella et al.   VALUE IN HEALTH